MetLife Investment Management, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 108 filers reported holding KURA ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 11.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$340,468
-10.4%
37,332
+4.0%
0.00%0.0%
Q2 2023$379,780
-13.5%
35,8960.0%0.00%0.0%
Q1 2023$439,008
-1.5%
35,8960.0%0.00%
-25.0%
Q4 2022$445,469
-6.7%
35,896
+2.7%
0.00%0.0%
Q3 2022$477,417
-25.5%
34,9500.0%0.00%
-20.0%
Q2 2022$640,634
+14.0%
34,9500.0%0.01%
+25.0%
Q1 2022$561,996
+69.2%
34,950
+47.3%
0.00%
+33.3%
Q4 2021$332,122
-25.3%
23,7230.0%0.00%
-25.0%
Q3 2021$444,332
-10.2%
23,7230.0%0.00%
-20.0%
Q2 2021$494,625
-26.2%
23,7230.0%0.01%
-16.7%
Q1 2021$670,649
-24.6%
23,723
-12.9%
0.01%
-33.3%
Q4 2020$889,626
+20.4%
27,239
+13.0%
0.01%
+12.5%
Q3 2020$738,669
+88.0%
24,1080.0%0.01%
+100.0%
Q2 2020$392,960
+189.3%
24,108
+76.6%
0.00%
+100.0%
Q1 2020$135,837
-27.6%
13,6520.0%0.00%0.0%
Q4 2019$187,715
-9.4%
13,6520.0%0.00%0.0%
Q3 2019$207,101
-23.0%
13,6520.0%0.00%
-33.3%
Q2 2019$268,808
+18.7%
13,6520.0%0.00%0.0%
Q1 2019$226,487
+18.2%
13,6520.0%0.00%
+50.0%
Q4 2018$191,674
-19.8%
13,6520.0%0.00%
-33.3%
Q3 2018$238,910
+29.8%
13,652
+35.1%
0.00%
+50.0%
Q2 2018$184,000
-2.6%
10,1020.0%0.00%0.0%
Q1 2018$189,000
+21.9%
10,1020.0%0.00%0.0%
Q4 2017$155,00010,1020.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders